Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis

BACKGROUND: Incretin therapy is feasible in patients with type 2 diabetes mellitus undergoing hemodialysis (HD). However, few studies have examined the safety and efficacy of this therapeutic approach in patients with diabetes and renal impairment. Here, we examined glycemic control and the anti-oxi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetol Metab Syndr
Main Authors: Terawaki, Yuichi, Nomiyama, Takashi, Takahashi, Hiroyuki, Tsutsumi, Yoko, Murase, Kunitaka, Nagaishi, Ryoko, Tanabe, Makito, Kudo, Tadachika, Kobayashi, Kunihisa, Yasuno, Tetsuhiko, Nakashima, Hitoshi, Yanase, Toshihiko
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4438630/
https://ncbi.nlm.nih.gov/pubmed/25995772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-015-0043-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados